Suchergebnisse - "2494G1JF75"

PubPharm (227)

1

Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic

enthalten in: Therapie | 2023

von Grandvuillemin, A. | Rocher, F. | Valnet-Rabier, M. | +3

2

Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19

enthalten in: European journal of hospital pharmacy : science and practice | 2023

von Skalafouris, C. | Samer, C. | Stirnemann, J. | +6

3

Concerted and multidisciplinary management of COVID-19 drug therapies during the first two epidemic waves in a tertiary hospital in Marseille, France : Results of the PHARMA-COVID study

enthalten in: PloS one | 2023

von Peretti, M. | Rebaudet, S. | Chiche, L. | +2

4

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

enthalten in: JAMA | 2023

von Writing Committee for the REMAP-CAP Investigators | Higgins, A. | Berry, L. | +164

CommentIn: JAMA. 2023 Jan 3;329(1):25-27. - PMID 36525259

5

Phylogenic analysis of coronavirus genome and molecular studies on potential anti-COVID-19 agents from selected FDA-approved drugs

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Ishola, A. | Adewole, K. | Tijjani, H. | +2

6

Quality of hospital emergency department care for patients with COVID-19 during the first wave in 2020 : the CALUR-COVID-19 study

enthalten in: Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias | 2022

von Jiménez, S. | Miró, �. | Alquézar-Arbé, A. | +8

7

Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment

enthalten in: Journal of pharmaceutical sciences | 2022

von Sahin, G. | Akbal-Dagistan, O. | Culha, M. | +4

8

Efficacy of pharmacological interventions in COVID-19 : A network meta-analysis

enthalten in: British journal of clinical pharmacology | 2022

von Selvarajan, S. | Anandaradje, A. | Shivabasappa, S. | +3

9

An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19 : final results

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Ader, F. | DisCoVeRy Study Group

10

Emerging Therapies for COVID-19 : The Value of Information From More Clinical Trials

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2022

von Dijk, S. | Krijkamp, E. | Kunst, N. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]